Zovirax Cream
$ 46,00 – $ 138,00Price range: $ 46,00 through $ 138,00
Zyban
$ 40,00 – $ 210,00Price range: $ 40,00 through $ 210,00
Zudena
$ 246,00 – $ 595,00Price range: $ 246,00 through $ 595,00
Zudena is a highly effective medication specifically designed to treat symptoms of erectile dysfunction in men. This advanced formula works by increasing blood flow to the pelvic region, helping to achieve and maintain a firm erection during sexual stimulation. The active ingredient, Udenafil, is known for its rapid onset of action and provides reliable support for up to twenty-four hours. Users appreciate this treatment for its ability to restore natural performance and confidence in intimate situations. Zudena offers a unique balance of speed and duration, making it a dependable choice for enhancing male sexual health.
Active substance: Udenafil
SKU:
Zudena
Category: Erectile Dysfunction
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Zudena belongs to a class of medications known as phosphodiesterase type 5 (PDE5) inhibitors. It is utilized primarily to assist in vascular smooth muscle relaxation to support erectile function under appropriate physiological stimulation. Regulated supply and distribution of this agent are dispensed in accordance with applicable federal and state regulations.
Understanding the therapeutic profile, metabolic pathway, and safety parameters of this compound is essential for optimal clinical outcomes. Healthcare providers evaluate individual patient history and underlying health conditions prior to recommending therapy within this pharmacological group.
Clinical Profile and Pharmacological Overview
| Property | Details |
|---|---|
| Active ingredient | Udenafil |
| Pharmacological class | PDE5 inhibitor |
| Dosage form | Oral tablet |
| Route of administration | Oral |
| Primary purpose | Treatment of erectile dysfunction |
| Prescription status | Dispensed in accordance with applicable federal and state regulations |
How the drug works: Udenafil acts through the selective inhibition of the enzyme phosphodiesterase type 5 (PDE5), which is predominantly expressed in the smooth muscle cells of the corpus cavernosum. By inhibiting PDE5, the degradation of cyclic guanosine monophosphate (cGMP) is restricted. Elevated levels of intracellular cGMP lead to smooth muscle relaxation and increased arterial blood flow into penile tissue during sexual arousal. It is important to emphasize that the mechanism of action depends on the endogenously released nitric oxide, meaning that physiological stimulation is required to initiate a response.
Main uses: The primary clinical indication for Udenafil is the treatment of erectile dysfunction in adult males. The medication addresses the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. Off-label indications must be explicitly evaluated and designated by a qualified prescriber; use of Udenafil for secondary cardiovascular conditions or pediatric vascular disorders remains off-label and requires strict specialized oversight. Patients must not use this agent for unapproved purposes without formal medical advice.
First days of treatment: Upon beginning treatment with Udenafil, individuals may observe variations in the onset and duration of physiological response. Pharmacological onset typically occurs within 30 to 60 minutes after oral ingestion. Patients should monitor for mild vasodilation effects during initial administration, such as minor flushing or transient headaches. Consistent efficacy relies on proper dosing timing relative to planned activity and strict adherence to initial clinical guidance.
Dosing schedule: The recommended dosing schedule must be tailored individually by a licensed provider based on clinical response and tolerability. Udenafil is administered orally with water, generally taken 30 to 60 minutes prior to intended sexual activity. Standard therapeutic protocols utilize single oral doses taken no more than once within a 24-hour period. Adjustments may be necessary for patients with hepatic or renal functional variations. Dosage modification should never be executed without direct consultation with a qualified medical professional.
What happens in the body: Following oral administration, Udenafil is absorbed from the gastrointestinal tract, achieving peak plasma concentration within approximately 1 to 1.5 hours. The compound undergoes extensive hepatic metabolism, primarily mediated by the cytochrome P450 3A4 (CYP3A4) isoenzyme system. Udenafil exhibits an elimination half-life that allows for an extended window of therapeutic activity compared to shorter-acting agents. Elimination occurs predominantly via the fecal route, with a smaller fraction excreted through renal pathways.
Compatibility with other medicines: Co-administration of Udenafil with organic nitrates or nitric oxide donors (such as nitroglycerin or isosorbide mononitrate) is strictly contraindicated due to the risk of severe, life-threatening hypotension. Concomitant use with alpha-blockers prescribed for hypertension or prostatic hypertrophy requires cautious dose titration to prevent symptomatic orthostatic hypotension. Strong CYP3A4 inhibitors (including ketoconazole, itraconazole, and erythromycin) can significantly increase plasma concentrations of Udenafil. Conversely, potent CYP3A4 inducers may reduce therapeutic efficacy. Full disclosure of prescription drugs, over-the-counter items, and dietary supplements to the clinical team is required.
Safety Parameters and Practical Considerations
Adverse reactions: Adverse reactions associated with Udenafil are primarily related to its vasodilatory properties. Frequently observed side effects include headache, facial flushing, nasal congestion, dyspepsia, and mild ocular discomfort or transient alterations in color vision. Less common adverse events involve dizziness, back pain, or myalgia. Although most adverse effects are mild and self-limiting, persistent symptoms require clinical evaluation. Rare but severe adverse events include sudden decrease or loss of hearing, non-arteritic anterior ischemic optic neuropathy (NAION), and priapism.
Important precautions: Assessment of underlying cardiovascular status is mandatory prior to initiating Udenafil, as sexual activity carries an inherent cardiac risk for patients with pre-existing heart disease. The drug should be used with extreme caution in patients with recent myocardial infarction, stroke, unstable angina, severe arrhythmia, or resting hypotension. Special populations, such as elderly patients or individuals with moderate hepatic impairment, require careful clinical monitoring. Udenafil is not indicated for use in pediatric populations or females; safety during pregnancy and lactation has not been established.
What to avoid while taking it: Udenafil may be taken with or without food; however, high-fat meals may delay the rate of absorption and peak plasma concentration. Moderate consumption of alcohol is advised, as excessive alcohol intake combined with PDE5 inhibition can compound vasodilatory effects, increasing the risk of orthostatic dizziness and low blood pressure. Patients should avoid consuming grapefruit juice, as it inhibits CYP3A4 metabolism and can lead to elevated circulating drug levels.
Red flags: Immediate emergency medical attention is required if patients experience severe adverse reactions. Critical warning signs include sudden chest pain, pressure radiating to the arm or jaw, severe dyspnea, or sudden loss of vision or hearing. A prolonged erection lasting longer than four hours (priapism) constitutes a medical emergency that requires prompt intervention to prevent permanent tissue damage. Signs of severe hypersensitivity, including facial swelling, lip swelling, or pharyngeal edema, also warrant immediate emergency care.
Storage and expiration: Udenafil tablets should be stored at controlled room temperature, between 59°F and 86°F (15°C to 30°C). Keep the medication in its original packaging to protect it from moisture and direct light exposure. Store out of reach of children and pets. Do not use the medication beyond the expiration date stamped on the packaging, and dispose of unused medication through official pharmaceutical disposal programs.
Common questions:
How does Udenafil differ in duration of action from short-acting options?
Udenafil exhibits a pharmacokinetic profile characterized by a moderate elimination half-life, which provides a broader window of therapeutic efficacy than short-acting PDE5 inhibitors while avoiding excessive systemic accumulation associated with daily-dose regimens.
Can Udenafil be taken on a continuous daily schedule?
While Udenafil is primarily prescribed for on-demand administration prior to anticipated activity, any consideration of continuous daily dosing must be formally evaluated and determined by a qualified prescriber based on specific patient parameters.
What steps should be taken if the expected effect is not achieved?
If initial therapeutic efficacy is insufficient, patients should not increase the dose independently. Factors such as administration timing, food intake, and the requirement for physiological stimulation should be reviewed with the prescribing provider.
Is it safe to drive or operate machinery after taking Udenafil?
Because Udenafil can cause dizziness, lightheadedness, or minor visual disturbances in sensitive individuals, patients should evaluate their individual response to the medication prior to driving or operating heavy equipment.
In accordance with applicable regulatory standards.
Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.
Additional information
| Dosage |
100mg |
|---|---|
| Package |
36 pills ,60 pills ,88 pills |
| Ενεργός Ουσία |
Related products
Abhigra
$ 69,00 – $ 173,00Price range: $ 69,00 through $ 173,00
Active substance: Sildenafil
More Details
This product has multiple variants. The options may be chosen on the product page
Apcalis SX Oral Jelly
$ 48,00 – $ 325,00Price range: $ 48,00 through $ 325,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Assurans
$ 50,00 – $ 70,00Price range: $ 50,00 through $ 70,00
Active substance: Sildenafil Citrate
More Details
This product has multiple variants. The options may be chosen on the product page
Aurogra
$ 49,00 – $ 219,00Price range: $ 49,00 through $ 219,00
Active substance: Sildenafil
More Details
This product has multiple variants. The options may be chosen on the product page
Bottled Cialis
$ 152,00 – $ 334,00Price range: $ 152,00 through $ 334,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Bottled Levitra
$ 158,00 – $ 347,00Price range: $ 158,00 through $ 347,00
Active substance: Vardenafil
More Details
This product has multiple variants. The options may be chosen on the product page
Cialis Jelly
$ 52,00 – $ 352,00Price range: $ 52,00 through $ 352,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Duratia
$ 43,00 – $ 526,00Price range: $ 43,00 through $ 526,00
Active substance: Dapoxetine
More Details
This product has multiple variants. The options may be chosen on the product page
